The co-blockade of TIM-3 and PD-L1 [45] or LAG-3 and PD-1 [44] enhanced the therapeutic efficacy, and increased the ratio of cytotoxic T cells: Tregs in the tumor compared to targeting PD-L1 or PD-1 alone. Here, LAG3 is linked to neoplasm.